|
CALM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29190000031087E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.24490000319844E-08 |
| Normal-vs-Stage2 |
8.603000E-01 |
| Normal-vs-Stage3 |
1.71565999999013E-05 |
| Normal-vs-Stage4 |
3.998300E-04 |
| Stage1-vs-Stage2 |
1.579550E-03 |
| Stage1-vs-Stage3 |
9.857000E-01 |
| Stage1-vs-Stage4 |
3.912800E-01 |
| Stage2-vs-Stage3 |
4.901600E-03 |
| Stage2-vs-Stage4 |
3.298100E-02 |
| Stage3-vs-Stage4 |
4.765600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.77119999462172E-08 |
| Normal-vs-AfricanAmerican |
3.176900E-03 |
| Normal-vs-Asian |
1.60151999999414E-05 |
| Caucasian-vs-AfricanAmerican |
7.339800E-01 |
| Caucasian-vs-Asian |
2.935000E-01 |
| AfricanAmerican-vs-Asian |
6.747800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.607700E-04 |
| Normal-vs-Female |
4.97609999872139E-08 |
| Male-vs-Female |
1.464840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.65950000197546E-08 |
| Normal-vs-Age(41-60Yrs) |
2.29650000016512E-07 |
| Normal-vs-Age(61-80Yrs) |
3.807600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.338500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.440400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.377260E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.464800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.023700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.723400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.311960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.274800E-01 |
| Classical-VS-Follicular |
1.76009995467297E-09 |
| Classical-VS-Other |
5.129000E-01 |
| Classical-VS-Normal |
4.43970415986428E-11 |
| Tall-VS-Follicular |
9.09859999564944E-08 |
| Tall-VS-Other |
4.129800E-01 |
| Tall-VS-Normal |
2.45329999648547E-08 |
| Follicular-VS-Other |
1.517630E-01 |
| Follicular-VS-Normal |
3.123200E-01 |
| Other-VS-Normal |
3.303000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.660600E-03 |
| Normal-vs-N1 |
6.721600E-03 |
| N0-vs-N1 |
4.781600E-01 |
|
|
